Net profit of Shree Ganesh Biotech India declined 96.88% to Rs 0.01 crore in the quarter ended September 2025 as against Rs 0.32 crore during the previous quarter ended September 2024. Sales declined 61.11% to Rs 0.77 crore in the quarter ended September 2025 as against Rs 1.98 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.771.98 -61 OPM %-51.951.01 - PBDT0.010.32 -97 PBT0.010.32 -97 NP0.010.32 -97 Powered by Capital Market - Live News

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live News

Shree Ganesh Biotech India announced that the Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live News

Net profit of Shree Ganesh Biotech India rose 37.50% to Rs 0.33 crore in the quarter ended June 2025 as against Rs 0.24 crore during the previous quarter ended June 2024. Sales declined 61.24% to Rs 1.38 crore in the quarter ended June 2025 as against Rs 3.56 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1.383.56 -61 OPM %-6.52-3.65 - PBDT0.330.24 38 PBT0.330.24 38 NP0.330.24 38 Powered by Capital Market - Live News

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 25 July 2025.Powered by Capital Market - Live News